A prospective cross-screening study on G-protein-coupled receptors: lessons learned in virtual compound library design

Journal of Medicinal Chemistry
Marijn P A SandersChris de Graaf

Abstract

We present the systematic prospective evaluation of a protein-based and a ligand-based virtual screening platform against a set of three G-protein-coupled receptors (GPCRs): the β-2 adrenoreceptor (ADRB2), the adenosine A(2A) receptor (AA2AR), and the sphingosine 1-phosphate receptor (S1PR1). Novel bioactive compounds were identified using a consensus scoring procedure combining ligand-based (frequent substructure ranking) and structure-based (Snooker) tools, and all 900 selected compounds were screened against all three receptors. A striking number of ligands showed affinity/activity for GPCRs other than the intended target, which could be partly attributed to the fuzziness and overlap of protein-based pharmacophore models. Surprisingly, the phosphodiesterase 5 (PDE5) inhibitor sildenafil was found to possess submicromolar affinity for AA2AR. Overall, this is one of the first published prospective chemogenomics studies that demonstrate the identification of novel cross-pharmacology between unrelated protein targets. The lessons learned from this study can be used to guide future virtual ligand design efforts.

References

Jul 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·C D StraderR A Dixon
Aug 20, 1996·Proceedings of the National Academy of Sciences of the United States of America·K WielandM J Lohse
Sep 13, 2000·The Journal of Biological Chemistry·A L ParrillG Tigyi
Jul 27, 2001·Current Opinion in Chemical Biology·P R CaronM A Murcko
Jan 29, 2002·Combinatorial Chemistry & High Throughput Screening·X ChenM K Gilson
Feb 12, 2002·Bioinformatics·Xi ChenMichael K Gilson
May 3, 2002·Biopolymers·X ChenM K Gilson
Mar 21, 2003·Journal of Medicinal Chemistry·Mark C WenlockPaul D Leeson
Mar 23, 2004·Mini Reviews in Medicinal Chemistry·E ter HaarS L Harbeson
May 8, 2004·Nature Reviews. Genetics·Markus Bredel, Edgar Jacoby
Jan 26, 2005·Journal of Chemical Information and Modeling·John J Irwin, Brian K Shoichet
Jun 10, 2005·Journal of Medicinal Chemistry·Renxiao WangShaomeng Wang
Jun 23, 2005·Proteins·Liegi HuHeather A Carlson
Sep 20, 2005·Journal of Molecular Graphics & Modelling·Richard D SmithHeather A Carlson
Dec 29, 2005·Medicinal Research Reviews·Stefano MoroGiampiero Spalluto
Jun 1, 2006·The Journal of Biological Chemistry·Huanchen WangHengming Ke
Sep 26, 2006·Drug Discovery Today·C John Harris, Adrian P Stevens
Jan 26, 2007·Nature Reviews. Cancer·Robert T Dorsam, J Silvio Gutkind
Mar 3, 2007·Journal of Computer-aided Molecular Design·Tudor I OpreaCristian G Bologa
May 30, 2007·British Journal of Pharmacology·T Klabunde
May 30, 2007·British Journal of Pharmacology·D Rognan
Aug 19, 2007·Current Protein & Peptide Science·A Srinivas ReddyG Narahari Sastry
Oct 9, 2007·Journal of Molecular and Cellular Cardiology·Fadi N SalloumRakesh C Kukreja
Nov 8, 2007·Nucleic Acids Research·Yasushi OkunoChunlai Feng
Nov 27, 2007·British Journal of Pharmacology·N MoitessierC R Corbeil
Nov 30, 2007·Combinatorial Chemistry & High Throughput Screening·Andreas BenderJohn W Davies
Jan 1, 2008·Journal of Molecular Graphics & Modelling·Truc-Chi T PhamAbby L Parrill
Apr 12, 2008·Nature Reviews. Drug Discovery·David M GoldsteinPatrick P Zarrinkar
Sep 10, 2008·Nature Biotechnology·Jordi MestresRicard V Solé
Nov 28, 2008·Journal of Biomolecular Screening·Miranda M C van Der LeeGuido J R Zaman
Jan 7, 2009·Journal of Chemical Information and Modeling·Andreas BenderJohn W Davies
May 13, 2009·Journal of Chemical Information and Modeling·Andreas SteffenOla Engkvist
May 13, 2009·Journal of Chemical Information and Modeling·Eelke van der HorstAdriaan P IJzerman
Oct 17, 2009·Journal of Medicinal Chemistry·Andrew R LeachRobin Taylor
Nov 3, 2009·Nature·Michael J KeiserBryan L Roth
Dec 24, 2009·Current Pharmaceutical Design·Chris de Graaf, Didier Rognan

❮ Previous
Next ❯

Citations

Dec 18, 2013·Journal of Chemical Information and Modeling·Trayder ThomasElizabeth Yuriev
Jul 28, 2015·Expert Opinion on Drug Discovery·Sid Topiol, Michael Sabio
Sep 21, 2013·Drug Discovery Today. Technologies·David E Gloriam
May 30, 2013·British Journal of Pharmacology·A J KooistraC de Graaf
Dec 26, 2012·Drug Discovery Today·Chris de GraafIwan J P de Esch
Jan 1, 2013·Computational and Structural Biotechnology Journal·Valère LounnasNicolas Foloppe
Jun 23, 2016·Chemical Reviews·Ali JazayeriFiona H Marshall
Oct 21, 2015·Trends in Molecular Medicine·Punita KumariArun K Shukla
Oct 28, 2016·Journal of Computer-aided Molecular Design·Eelke B LenselinkAdriaan P IJzerman
Jun 25, 2016·Scientific Reports·Albert J KooistraChris de Graaf
Jul 30, 2014·Methods : a Companion to Methods in Enzymology·Ashutosh Kumar, Kam Y J Zhang
Dec 20, 2013·ChemMedChem·Stephen P AndrewsJohn A Christopher
Mar 1, 2017·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Damian BartuziDariusz Matosiuk
Apr 28, 2021·Angewandte Chemie·Stefanie KampenJens Carlsson

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.